The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
Many people are thinking of their New Year's resolutions and resetting goals. Phyllis Ehrlich, career coach and president of Rocket Your Potential, joined Cheddar News to provide tips on how to polish up your resume for 2024 and explain why you should.
A 6-year-old boy who left on a flight for the Christmas holiday to visit his grandmother in southwest Florida instead was put on the wrong plane and ended up 160 miles away in Orlando, Florida.
Apple filed an emergency motion seeking court permission to begin selling two of its most popular watches again until a final decision on its broader appeal in a bitter patent dispute is decided.
